These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23812486)

  • 1. ACOG Committee Opinion No. 565: Hormone therapy and heart disease.
    Obstet Gynecol; 2013 Jun; 121(6):1407-1410. PubMed ID: 23812486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
    Bassuk SS; Manson JE
    Metabolism; 2016 May; 65(5):794-803. PubMed ID: 27085786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
    Manson JE; Bassuk SS
    Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
    Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
    F1000Res; 2019; 8():. PubMed ID: 31543950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
    Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
    Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy.
    Bhavnani BR; Strickler RC
    J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should symptomatic menopausal women be offered hormone therapy?
    Lobo RA; Bélisle S; Creasman WT; Frankel NR; Goodman NE; Hall JE; Ivey SL; Kingsberg S; Langer R; Lehman R; McArthur DB; Montgomery-Rice V; Notelovitz M; Packin GS; Rebar RW; Rousseau M; Schenken RS; Schneider DL; Sherif K; Wysocki S
    MedGenMed; 2006; 8(2):1 p preceding 35. PubMed ID: 17048337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Timing Hypothesis: Hormone Therapy for Treating Symptomatic Women During Menopause and Its Relationship to Cardiovascular Disease.
    Mehta JM; Chester RC; Kling JM
    J Womens Health (Larchmt); 2019 May; 28(5):705-711. PubMed ID: 30484736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Research on the Implications of Hormone Replacement Therapy on Coronary Heart Disease.
    Keck C; Taylor M
    Curr Atheroscler Rep; 2018 Oct; 20(12):57. PubMed ID: 30350133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should symptomatic menopausal women be offered hormone therapy?
    Lobo RA; Bélisle S; Creasman WT; Frankel NR; Goodman NF; Hall JE; Ivey SL; Kingsberg S; Langer R; Lehman R; McArthur DB; Montgomery-Rice V; Notelovitz M; Packin GS; Rebar RW; Rousseau M; Schenken RS; Schneider DL; Sherif K; Wysocki S
    MedGenMed; 2006; 8(3):40. PubMed ID: 17410686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG committee opinion. Risk of breast cancer with estrogen-progestin replacement therapy.
    American College of Obstetricians and Gynecologists, Committee on Gynecologic Practice
    Int J Gynaecol Obstet; 2002 Mar; 76(3):333-5. PubMed ID: 11995613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone use for cardioprotection: what we know and what we must learn.
    Wenger NK
    Curr Opin Cardiol; 1999 Jul; 14(4):292-7. PubMed ID: 10448608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.